Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Intravitreal interleukin-6 inhibition with vamikibart in sarcoidosis-associated uveitis

Meike Pauly-Evers; Zeinab Barekati; Federica Storti; William Holmes; Laura Steeples; Zdenka Haskova; Phoebe Lin; Sumit Sharma; Sascha Fauser; Marina Mesquida

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2611.

ARVO Annual Meeting Abstract June 2024

Volumetric fluid dynamics using machine-learning augmented analysis in patients with uveitic macular edema receiving vamikibart in the DOVETAIL study

Karen Matar; Yavuz Cakir; Hasan Cetin; Reem Amine; Michelle Bonnay; Conor Anthony Mcconville; Sunil K Srivastava; Meike Pauly-Evers; Zeinab Barekati; Federica Storti; Sumit Sharma; Sascha Fauser; Marina Mesquida; Justis Ehlers

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3029.

ARVO Annual Meeting Abstract June 2024

Longitudinal quantitative ultra-widefield fluorescein angiography leakage dynamics in patients with uveitic macular edema following intravitreal anti–IL-6 therapy with vamikibart

Yavuz Cakir; Karen Matar; Hasan Cetin; Reem Amine; Michelle Bonnay; Conor Anthony Mcconville; Sunil K Srivastava; Meike Pauly-Evers; Zeinab Barekati; Federica Storti; Sumit Sharma; Sascha Fauser; Marina Mesquida; Justis Ehlers

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2628.

ARVO Annual Meeting Abstract June 2024

Longitudinal Quantitative Anterior Chamber Cell Analysis Following Vamikibart Intravitreal Therapy in Patients with Uveitic Macular Edema from the DOVETAIL Clinical Trial

Sumit Sharma; Abel Hamden; Cindy Chen; Sandeep Singh; Phuoc-Hanh Le; Kimberly Baynes; Meike Pauly-Evers; Zeinab Barekati; Federica Storti; Sascha Fauser; Marina Mesquida; Sunil K Srivastava

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3028.

ARVO Annual Meeting Abstract June 2024

Aqueous humor interleukin-6 levels in uveitic macular edema: baseline characteristics from the phase 1 DOVETAIL study

Zeinab Barekati; William Holmes; Tamara von Donge; Meike Pauly-Evers; Robbie Peck; Daniela Willen; Benedicte Passemard; Sascha Fauser; Marina Mesquida; Federica Storti

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3021.

ARVO Annual Meeting Abstract June 2023

A novel intravitreal anti-IL-6 monoclonal antibody for uveitic macular edema (UME): preliminary results from the phase 1 DOVETAIL study

Sumit Sharma; Eric Suhler; Phoebe Lin; Meike Pauly-Evers; Daniela Willen; Robbie Peck; Federica Storti; Simone Rauhut; Tatiana Gott; Benedicte Passemard; Lachlan Macgregor; Zdenka Haskova; David Silverman; Sascha Fauser; Marina Mesquida

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5100.

ARVO Annual Meeting Abstract July 2018

Anti-VEGF/anti-angiopoietin-2 bispecific antibody RG7716 in diabetic macular edema: complete 36-week results from the phase 2, multicenter, randomized, active treatment-controlled BOULEVARD clinical trial

Sunil S Patel; Jayashree Sahni; Shamil Sadikhov; Meike Pauly-Evers; Piotr Szczesny; Robert Weikert

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1959.

Advertisement